There's a shopping bonanza for new obesity medicines going on among a marquee cohort of biopharma investors who are ...

French biotech MaaT Pharma says its acute graft-versus-host disease treatment exceeded expectations in a single-arm Phase 3 ...

Baby with genetic OTC deficiency shows promising response to iECURE's first-in-kind gene therapy, potentially avoiding liver ...

Revance Therapeutics said Wednesday it will have talks with Teoxane on its bid to take over Revance's company. But Crown ...

Transcarent acquires Accolade for $621M in cash deal led by CEO Glen Tullman, combining health navigation platforms.

Astellas has ended work on a cell therapy that it was exploring for CD20-positive B cell lymphomas, the Japan-based pharma ...

National Resilience is laying off 120 staffers from its gene therapy facility in North Carolina, only a month after the San ...

Aspect Biosystems raises $115M Series B for bioprinted tissue therapeutics targeting diabetes and metabolic disorders, led by ...

Ahead of the busiest week for biopharma dealmaking at the annual JP Morgan Healthcare Conference, a new startup launched, ...

Roche's Chugai partners with Araris Biotech on multi-payload ADCs, as Swiss biotech advances tech allowing multiple cytotoxic ...

Novo Nordisk is doubling down on its computational biotech partner Valo Health, expanding their collaboration from 11 ...

A private startup looking to bring an old schizophrenia drug class to the US has released new Phase 2 data and aims to start ...